GERM vs. SBIO
Compare and contrast key facts about ETFMG Treatments Testing and Advancements ETF (GERM) and ALPS Medical Breakthroughs ETF (SBIO).
GERM and SBIO are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. GERM is a passively managed fund by ETFMG that tracks the performance of the Prime Treatments, Testing and Advancements Index. It was launched on Jun 17, 2020. SBIO is a passively managed fund by SS&C that tracks the performance of the S-Network Medical Breakthroughs Index. It was launched on Dec 31, 2014. Both GERM and SBIO are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GERM or SBIO.
Correlation
The correlation between GERM and SBIO is 0.03, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
GERM vs. SBIO - Performance Comparison
Key characteristics
Returns By Period
GERM
N/A
N/A
N/A
N/A
N/A
N/A
SBIO
-1.39%
5.20%
-9.60%
-3.80%
-4.36%
2.13%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
GERM vs. SBIO - Expense Ratio Comparison
GERM has a 0.68% expense ratio, which is higher than SBIO's 0.50% expense ratio.
Risk-Adjusted Performance
GERM vs. SBIO — Risk-Adjusted Performance Rank
GERM
SBIO
GERM vs. SBIO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for ETFMG Treatments Testing and Advancements ETF (GERM) and ALPS Medical Breakthroughs ETF (SBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
GERM vs. SBIO - Dividend Comparison
GERM has not paid dividends to shareholders, while SBIO's dividend yield for the trailing twelve months is around 3.60%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
GERM ETFMG Treatments Testing and Advancements ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SBIO ALPS Medical Breakthroughs ETF | 3.60% | 3.55% | 0.22% | 0.00% | 0.00% | 0.00% | 0.04% | 2.79% | 1.77% |
Drawdowns
GERM vs. SBIO - Drawdown Comparison
Volatility
GERM vs. SBIO - Volatility Comparison
The current volatility for ETFMG Treatments Testing and Advancements ETF (GERM) is 0.00%, while ALPS Medical Breakthroughs ETF (SBIO) has a volatility of 6.40%. This indicates that GERM experiences smaller price fluctuations and is considered to be less risky than SBIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.